查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930144

全球牛隻疫苗市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量因素以及未來預測（2026-2034）

Bovine Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 請詢問到貨日

價格

牛隻疫苗市場成長因素

全球牛隻疫苗市場在保護牛群健康和確保全球肉類及乳製品品質方面發揮著至關重要的作用。牛用疫苗廣泛用於預防嚴重影響畜牧業生產力和農場經濟的傳染病，例如口蹄疫、出血性敗血症、黑蹄病、布魯氏菌病、乳腺炎和鈍性皮膚病。

根據這份報告，2025年全球牛用疫苗市場價值為39億美元。預計到2026年，該市場將成長至40.4億美元，到2034年將達到63.2億美元，在預測期（2026-2034年）內，複合年增長率（CAGR）為5.76%。這種穩定增長反映了疾病的日益普及、對乳製品和肉類產品需求的增長以及人們對預防性獸醫保健意識的提高。

市場驅動因素

推動牛用疫苗市場成長的關鍵因素之一是畜牧業傳染病的日益普及。僅口蹄疫就影響了全球約 77.0% 的牲畜，凸顯了廣泛接種疫苗的必要性。此外，乳腺炎等疾病給農民帶來了沉重的經濟負擔，導致牲畜提前淘汰和生產力下降。

全球對乳製品和肉類產品的需求不斷增長，也進一步加速了疫苗的普及。全球數百萬頭乳牛用於牛奶生產，因此疾病預防對於維持優質產品和穩定供應至關重要。此外，農民對動物福利和健康保健意識的提高，也推動了疫苗接種率的提高和對牲畜健康管理計畫的投資。

市場限制因子

儘管成長前景光明，但由於發展中國家疫苗接種覆蓋率有限，市場仍面臨挑戰。獸醫基礎設施匱乏、意識薄弱和經濟限制阻礙了低收入地區的疫苗普及。每年仍有相當比例的牲畜因傳染病而死亡，這凸顯了疫苗接種覆蓋率的差距。

市場機會

牛疫苗市場蘊藏著巨大的機遇，這主要得益於研發部門致力於開發針對新發和地方性疾病的疫苗。生物技術和免疫學的進步使得開發更具針對性和有效性的疫苗成為可能。新一代疫苗和重組疫苗等創新技術在提高疾病控制的同時，也提升了牛群的生產力。

市場挑戰

高昂的研發成本和嚴格的監管審批流程給市場參與者帶來了重大挑戰。監管壁壘往往會延長產品研發週期，尤其是對於重組疫苗和新型疫苗而言。這些挑戰可能會限制發展中地區獲得價格合理的疫苗，並延緩創新解決方案的推廣應用。

新興市場趨勢

推動市場發展的關鍵趨勢之一是開發用於牛隻健康的mRNA疫苗。這項技術能夠加快疫苗研發速度，更能適應新出現的病原體，並有可能同時針對多種疾病。大型企業之間的策略聯盟正在加速先進疫苗平台的商業化，並影響全球獸用疫苗市場格局。

市場區隔分析

依產品類型劃分，市場可分為：滅活疫苗、減毒活疫苗、重組疫苗和其他疫苗。滅活疫苗市場佔有率最大，這主要歸功於其高效性、不斷推出的新產品以及獲得監管部門的批准。減毒活疫苗也保持相當可觀的市場佔有率，而重組疫苗由於其成本效益高、品質不斷提高，預計將以顯著的複合年增長率增長。

依給藥途徑劃分，市場可分為注射劑、口服劑及鼻腔給藥劑。注射劑疫苗因其高免疫反應和快速起效而佔市場主導地位。鼻腔和口服疫苗因其易於接種且適用於大規模疫苗接種計劃而備受關注。

依分銷管道劃分，獸醫院在政府主導的疫苗接種運動和疾病控制計劃的支持下佔市場主導地位。由於服務可及性提高和獸醫數量增加，獸醫診所和藥房的市場佔有率也呈現穩定成長。

區域展望

截至2025年，北美將主導牛隻疫苗市場，佔46.50%的市場佔有率，區域市場規模將達到18.1億美元。健全的監管框架、對動物健康的重視以及大量的研發投入支撐了該地區的優勢。

由於人畜共患病的日益普及和政府支持的疫苗接種計劃，歐洲預計將保持穩定成長。由於乳製品產量的增加、疾病發病率的上升以及對畜牧業的日益重視，亞太地區預計將實現顯著增長。由於政府主導的疫苗接種計畫增加，預計拉丁美洲和中東及非洲地區將出現溫和成長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家和地區的牛病概述（2025 年）
  • 主要國家和地區的監管現狀（2025 年）
  • 牛病疫苗接種概述
  • 主要公司的新產品發布
  • 主要產業趨勢：併購、業務合作等
  • 影響COVID-19 對全球牛隻疫苗市場的影響

第五章 全球牛隻疫苗市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品分類
    • 滅活​​疫苗
    • 減毒活疫苗
    • 重組疫苗
    • 其他
  • 市場分析、洞察與預測：依給藥途徑
    • 口服
    • 注射
    • 鼻腔給藥
  • 市場分析、洞察與預測：依銷售管道
    • 獸醫院
    • 獸醫診所
    • 藥局
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美牛隻疫苗市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲牛疫苗市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 其他歐洲國家

第八章亞太地區牛隻疫苗市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲牛疫苗市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲牛疫苗市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會（海灣合作委員會）國家
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 世界市場佔有率分析(2025年)
  • 企業簡介
    • Elanco
    • HIPRA
    • Boehringer Ingelheim International GmbH
    • Virbac
    • Merck &Co., Inc.
    • Zoetis Services LLC
    • Ceva
    • Indian Immunologicals Ltd.
Product Code: FBI112837

Growth Factors of bovine vaccines Market

The global bovine vaccines market plays a critical role in safeguarding cattle health and ensuring the quality of meat and dairy products worldwide. Bovine vaccines are widely used to prevent infectious diseases such as Foot and Mouth Disease (FMD), hemorrhagic septicemia, black quarter, brucellosis, mastitis, and lumpy skin disease, which significantly affect livestock productivity and farm economics.

According to the report, the global bovine vaccines market size was valued at USD 3.9 billion in 2025. The market is projected to grow to USD 4.04 billion in 2026 and further reach USD 6.32 billion by 2034, registering a compound annual growth rate (CAGR) of 5.76% during the forecast period (2026-2034). This steady growth reflects increasing disease prevalence, rising demand for dairy and meat products, and growing awareness of preventive veterinary care.

Market Drivers

One of the primary factors driving the bovine vaccines market growth is the rising prevalence of infectious livestock diseases. Foot and Mouth Disease alone affects nearly 77.0% of the global livestock population, creating a strong need for widespread immunization. Additionally, diseases such as mastitis impose substantial financial burdens on farmers, leading to premature culling and productivity losses.

The growing global demand for milk and meat further accelerates vaccine adoption. Millions of dairy cows are used globally for milk production, increasing the necessity for disease prevention to maintain yield quality and supply consistency. Moreover, increased farmer awareness regarding animal welfare and preventive healthcare has resulted in higher vaccination rates and investments in livestock health management programs.

Market Restraints

Despite positive growth prospects, the market faces challenges due to limited uptake of immunization in developing countries. Inadequate veterinary infrastructure, low awareness, and economic constraints restrict vaccine penetration in lower-income regions. A significant proportion of preventable livestock deaths still occur annually due to infectious diseases, highlighting the gap in vaccination coverage.

Market Opportunities

The bovine vaccines market offers strong opportunities driven by research and development initiatives focused on launching vaccines for emerging and region-specific diseases. Advances in biotechnology and immunology have enabled the development of more targeted and effective vaccines. Innovations such as next-generation and genetically engineered vaccines are improving disease control while enhancing herd productivity.

Market Challenges

High development costs and stringent regulatory approval processes present key challenges for market players. Regulatory hurdles often extend product development timelines, especially for genetically engineered and novel vaccines. These challenges can limit the availability of affordable vaccines in developing regions and slow the adoption of innovative solutions.

Emerging Market Trends

An important trend shaping the market is the development of mRNA vaccines for bovine health. This technology allows faster vaccine development, adaptability to emerging pathogens, and the potential to target multiple diseases simultaneously. Strategic collaborations among leading companies are accelerating the commercialization of advanced vaccine platforms, influencing global veterinary vaccine trends.

Segmentation Analysis

By product, the market is segmented into inactivated, live attenuated, recombinant, and others. The inactivated vaccines segment holds the largest market share due to higher efficacy, increased product launches, and regulatory approvals. Live attenuated vaccines also maintain a substantial share, while recombinant vaccines are expected to grow at a notable CAGR due to cost-effective production and improved quality.

Based on route of administration, the market includes parenteral, oral, and intranasal vaccines. The parenteral segment dominates owing to high immune response and faster onset of action. Intranasal and oral routes are gaining traction due to ease of administration and suitability for mass vaccination programs.

By distribution channel, veterinary hospitals lead the market, supported by government-led vaccination campaigns and disease control programs. Veterinary clinics and pharmacies are also witnessing steady growth due to improved accessibility and rising veterinary practitioner numbers.

Regional Outlook

North America dominated the bovine vaccines market in 2025, accounting for a 46.50% market share, with a regional market size of USD 1.81 billion. Strong regulatory frameworks, high awareness of animal health, and significant R&D investments support regional dominance.

Europe is expected to grow steadily due to increasing zoonotic disease prevalence and government-backed vaccination initiatives. The Asia Pacific region is projected to register significant growth, driven by expanding dairy production, rising disease incidence, and growing focus on animal husbandry. Latin America and the Middle East & Africa are anticipated to witness moderate growth supported by increasing government vaccination programs.

Competitive Landscape

The market is characterized by the presence of established players with strong product portfolios and active R&D strategies. Key companies include Zoetis Services LLC, Merck & Co., Inc., Elanco, HIPRA, Boehringer Ingelheim International GmbH, Virbac, Ceva, and Indian Immunologicals Ltd. Continuous product launches, regulatory approvals, and strategic collaborations remain central to maintaining competitive positioning.

Conclusion

The global bovine vaccines market demonstrates steady and sustainable growth, supported by the increasing burden of infectious cattle diseases and the rising global demand for safe, high-quality dairy and meat products. Valued at USD 3.9 billion in 2025, the market is expected to reach USD 4.04 billion in 2026 and further expand to USD 6.32 billion by 2034, growing at a CAGR of 5.76% during 2026-2034. Strong adoption of preventive veterinary care, especially in developed regions such as North America, continues to strengthen market expansion.

Advancements in vaccine technologies, including inactivated, recombinant, and emerging mRNA-based vaccines, along with increasing research and development initiatives, are enhancing disease prevention and herd productivity. At the same time, government-led vaccination programs and growing awareness among farmers are improving vaccine uptake across key regions. Although challenges such as high development costs, regulatory hurdles, and limited immunization coverage in developing economies persist, ongoing innovation and strategic collaborations among leading players are expected to sustain market growth and improve global bovine health outcomes over the forecast period.

Segmentation By Product

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Intranasal

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • U.S.
    • Canada
  • Europe (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of Bovine Diseases by Key Countries, By Key Countries/ Region, 2025
  • 4.2. Regulatory Scenario by Key Countries/ Region, 2025
  • 4.3. Overview of Vaccination for Bovine Diseases
  • 4.4. New Product Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.6. Impact of COVID-19 on the Global Bovine Vaccines Market

5. Global Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.2.1. Oral
    • 5.2.2. Parenteral
    • 5.2.3. Intranasal
  • 5.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.3.1. Veterinary Hospitals
    • 5.3.2. Veterinary Clinics
    • 5.3.3. Pharmacies & Drug Stores
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.2.1. Oral
    • 6.2.2. Parenteral
    • 6.2.3. Intranasal
  • 6.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.3.1. Veterinary Hospitals
    • 6.3.2. Veterinary Clinics
    • 6.3.3. Pharmacies & Drug Stores
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.2.1. Oral
    • 7.2.2. Parenteral
    • 7.2.3. Intranasal
  • 7.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.3.1. Veterinary Hospitals
    • 7.3.2. Veterinary Clinics
    • 7.3.3. Pharmacies & Drug Stores
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.2.1. Oral
    • 8.2.2. Parenteral
    • 8.2.3. Intranasal
  • 8.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.3.1. Veterinary Hospitals
    • 8.3.2. Veterinary Clinics
    • 8.3.3. Pharmacies & Drug Stores
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.2.1. Oral
    • 9.2.2. Parenteral
    • 9.2.3. Intranasal
  • 9.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.3.1. Veterinary Hospitals
    • 9.3.2. Veterinary Clinics
    • 9.3.3. Pharmacies & Drug Stores
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.2.1. Oral
    • 10.2.2. Parenteral
    • 10.2.3. Intranasal
  • 10.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.3.1. Veterinary Hospitals
    • 10.3.2. Veterinary Clinics
    • 10.3.3. Pharmacies & Drug Stores
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Elanco
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. HIPRA
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Boehringer Ingelheim International GmbH
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Virbac
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Merck & Co., Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Zoetis Services LLC
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Ceva
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Indian Immunologicals Ltd.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2034
  • Table 2: Global Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2034
  • Table 3: Global Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2034
  • Table 4: Global Bovine Vaccines Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2034
  • Table 6: North America Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2034
  • Table 7: North America Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2034
  • Table 8: North America Bovine Vaccines Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2034
  • Table 10: Europe Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2034
  • Table 11: Europe Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2034
  • Table 12: Europe Bovine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2034
  • Table 14: Asia Pacific Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2034
  • Table 15: Asia Pacific Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2034
  • Table 16: Asia Pacific Bovine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2034
  • Table 18: Latin America Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2034
  • Table 19: Latin America Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2034
  • Table 20: Latin America Bovine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2034
  • Table 22: Middle East & Africa Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2034
  • Table 23: Middle East & Africa Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2034
  • Table 24: Middle East & Africa Bovine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Bovine Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Bovine Vaccines Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Bovine Vaccines Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 4: Global Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 5: Global Bovine Vaccines Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Bovine Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 7: North America Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 8: North America Bovine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 9: North America Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 10: North America Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 11: North America Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 12: North America Bovine Vaccines Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Bovine Vaccines Market Value Share (%), By Country, 2025
  • Figure 14: Europe Bovine Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 15: Europe Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 16: Europe Bovine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 17: Europe Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 18: Europe Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 19: Europe Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 20: Europe Bovine Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Bovine Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 23: Asia Pacific Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 24: Asia Pacific Bovine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 25: Asia Pacific Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 26: Asia Pacific Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 27: Asia Pacific Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 28: Asia Pacific Bovine Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Bovine Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 31: Latin America Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 32: Latin America Bovine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 33: Latin America Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 34: Latin America Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 35: Latin America Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 36: Latin America Bovine Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Bovine Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 39: Middle East & Africa Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 40: Middle East & Africa Bovine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 41: Middle East & Africa Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 42: Middle East & Africa Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 43: Middle East & Africa Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 44: Middle East & Africa Bovine Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Bovine Vaccines Market Share (%), By Company, 2025